| 000 | 01205 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512115839.0 | ||
| 264 | 0 | _c19721025 | |
| 008 | 197210s 0 0 eng d | ||
| 022 | _a0008-4182 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilkie, J | |
| 245 | 0 | 0 |
_aThe effect of rifampicin on Pseudomonas keratitis. _h[electronic resource] |
| 260 |
_bCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _cJul 1972 |
||
| 300 |
_a309-13 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aConjunctiva _xdrug effects |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 |
_aDimethyl Sulfoxide _xpharmacology |
| 650 | 0 | 4 |
_aEdetic Acid _xpharmacology |
| 650 | 0 | 4 |
_aGentamicins _xtherapeutic use |
| 650 | 0 | 4 |
_aKeratitis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aSmolin, G | |
| 700 | 1 | _aOkumoto, M | |
| 773 | 0 |
_tCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _gvol. 7 _gno. 3 _gp. 309-13 |
|
| 999 |
_c4630655 _d4630655 |
||